StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Lipella Pharmaceuticals

Lipella Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Lipella Pharmaceuticals figures

See a number that looks wrong?